The Cost of Overweight and Obesity on the Island of Ireland

Size: px
Start display at page:

Download "The Cost of Overweight and Obesity on the Island of Ireland"

Transcription

1 t The Cost of Overweight and Obesity on the Island of Ireland Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. JANPA Launch- WP 4 Meeting September 2015

2 Acknowledgements UCC/ HSE Department of Public Health, Limerick Dr Anne Dee, Karen Kearns, Victoria O Dwyer NUIG - Professor Ciaran O Neill, Dr. Edel Doherty, Dr. Aoife Callan DCU - Professor Anthony Staines, Dr. Treasa McVeigh, Dr. MaryRose Sweeney QUB - Professor Frank Kee, John Hughes National Cancer Registry - Dr. Linda Sharp Institute of Public Health - Professor Kevin Balanda Safefood- Dr Cliodhna Foley-Nolan

3 Main findings in BMJ open

4 Overview Brief overview of the obesity epidemic in adults and children in Ireland Burden of disease linked to obesity Background to the Irish Cost of Obesity Study including earlier international work on this issue Methods used in Irish Cost of Obesity Study Main findings and Recommendations Pitfalls and limitations

5 Economist magazine Dec 11th 2003

6 Past and projected prevalence of overweight in selected countries

7 Overweight and obesity in children in selected countries

8 Overweight and obesity in Irish adults (18-64 years) in 1990, 2001 and 2011

9 SLÁN(measured BMI) vs TILDA(measured BMI) in middle-aged and older adults 90% 80% 70% 31% 37% 60% 34% 32% 31% 50% 25% 40% 30% 20% 49% 39% 39% 47% 40% 44% 10% 0% Slán 2007 Males 45+ Slán 2007 Females 45+ Slán 2007 Male & Female TILDA 2011 Males 50+ TILDA 2011 Females 50+ TILDA 2011 Male & Female Obesity Overweight

10 Childhood overweight & obesity prevalence in Ireland 2002 to 2014 Keane et al BMC Public Health 2014

11 Overview Brief overview of the obesity epidemic in adults and children in Ireland Burden of disease linked to obesity Background to the Irish Cost of Obesity Study including earlier international work on this issue Methods used in Irish Cost of Obesity Study Main findings and Recommendations Pitfalls and limitations

12 Likelihood of developing Type II diabetes attributable to overweight & obesity in males & females 1200% 1141% 1000% 800% 600% 574% 400% 292% 200% 140% 0% Male overweight Male obese Female overweight Female obese

13 Liklihood of developing cancers attributable to overweight & obesity in males 140% 129% 120% 100% 80% 95% 82% 60% 40% 20% 0% 15% 13% 21% 40% 28% 5% 25% Male Overweight Male Obese

14 Liklihood of developing cancers attributable to overweight & obesity in females 250% 222% 200% 164% 150% 100% 50% 0% 8% 13% Breast Post menopausal 82% 85% 66% 60% 53% 45% 35% 20% 24% 15% Large Bowel Uterus Oesophagus Kidney Pancreas Gall bladder Female Overweight Female obese

15 Liklihood of developing chronic illness attributable to overweight & obesity in males 300% 250% 251% 200% 210% 181% 150% 142% 100% 50% 65% 80% 27% 78% 15% 49% 91% 59% 96% 80% 0% High Blood Pressure Coronary Heart Disease Heart Failure Stroke Clot on Lung (PE) Back Pain Osteoarthritis

16 Liklihood of developing chronic illness attributable to overweight & obesity- females 300% 250% 200% 210% 251% 181% 150% 142% 100% 50% 0% 65% 80% 27% 78% 15% 49% 91% 59% 96% 80% Female overweight Female obese

17 Global Burden of Disease 2010

18 Overview Brief overview of the obesity epidemic in adults and children in Ireland Burden of disease linked to obesity Background to the Irish Cost of Obesity Study including earlier international work on this issue Methods used in Irish Cost of Obesity Study Main findings and Recommendations Pitfalls and limitations

19 Background Safefood initiative-obesity Taskforce Report 2005 highlighted the lack of information on the economic burden of overweight and obesity Comprehensive assessment of the cost of overweight and obesity in Ireland Began April 2011

20 Project aims and objectives The overall aim of the project was to provide a comprehensive assessment of the cost of overweight and obesity on the island of Ireland Objectives To review and summarise the international literature on cost of obesity studies with a particular focus on those published since 2001, with a view to guiding and informing the approach adopted in the current project. To determine the direct health service related costs of overweight and obesity in the Republic of Ireland and Northern Ireland from a public health care payer perspective. To estimate the indirect cost, due to sickness, absence and premature mortality, related to overweight and obesity in both the Republic of Ireland and in Northern Ireland. To examine the combined health service and lost production costs associated with overweight and obesity, and examine variations in these estimates across illnesses and jurisdictions. To make recommendations based on the findings

21 Cost of obesity studies in the international literature since 2001

22 Range of Study Designs Top down:-based on estimation of population attributable fractions (PAF method) Bottom up: - based on analyses of cross-sectional and/or longitudinal datasets Mixed approaches

23 Literature review - what have other countries found? Overweight and obesity account for somewhere between 1% and 9% of total healthcare costs Indirect costs may be as much again or even more Costs increase with increasing BMI

24 Conclusions from Literature Review On an individual level the highest BMI groups are most costly On a population level the overweight group are more costly as they are a larger group

25 Overview Brief overview of the obesity epidemic in adults and children in Ireland Burden of disease linked to obesity Background to the Irish Cost of Obesity Study including earlier international work on this issue Methods used in Irish Cost of Obesity Study Main findings and Recommendations Pitfalls and limitations

26 What costs were included? Most comprehensive studies measure direct and indirect costs overweight and obesity Direct Costs include: In-Patient Out-patient General Practice Drugs and prescribing costs Indirect Costs include lost productivity due to: Time off work due to overweight and obesity related illness Premature mortality

27 Chronic conditions associated with overweight & obesity Cancers Colon Oesophageal Post-Menopausal Breast Endometrial Kidney Gallbladder Pancreas Other Type 2 Diabetes Cardiovascular Disease Hypertension Cardiac Failure Venous thromboembolism Asthma Gallbladder Disease Low Back Pain Osteoarthritis Gout

28 Top down:- PAF method inputs Estimated prevalence of overweight and obesity List of co-morbid conditions associated with overweight & obesity The magnitude of the causal association between overweight & obesity and each condition, expressed as a relative risk (RR) with 95% confidence intervals PAF estimated from the PF (fraction of the population exposed to overweight plus the fraction exposed to obesity) and the magnitude of the estimated RR (relative risk) of disease associated with both overweight and obesity National cost data from hospital discharge data (HIPE) or other sources as appropriate.

29 Meta-analysis of studies of overweight & obesity and Type 2 diabetes** **Prospective cohort studies of sufficient size reporting risk estimate based on the incidence of disease)

30 Bottom up cross-sectional approach Based on the analyses of cross-sectional survey data for healthcare usage and productivity loss (e.g. absenteeism) by BMI category. Highly dependent on the quality of the available data on health outcomes and productivity loss and the representativeness of the sample. Also dependent on the availability of cost data, either directly as a core element of the dataset or via resource use information that can be linked to average cost data

31 Methods used in the all Ireland cost of obesity study

32 Data sources and methods for direct costs Top down:paf method Hospital Inpatient Enquiry (HIPE) & the Primary Care Reimbursement Scheme (PCRS) databases in the Republic of Ireland Hospital Inpatient System (HIS) and the Business Services Organisation (BSO) databases in Northern Ireland. Bottom up cross-sectional method Regression analyses of associations between overweight and obesity and self-reported health care utilisation in: the SLÁN 2007 dataset (Republic of Ireland) the Irish National Longitudinal Study of Ageing (TILDA) datasets (Republic of Ireland) the 2010/11 Health Survey Northern Ireland.

33 Data sources for indirect costs Sickness related absenteeism Republic of Ireland: the SLÁN 2007 dataset were analysed for evidence of associations between overweight and obesity and self-reported absenteeism during the previous year, using regression analyses similar to those used in the estimation of direct costs. the Department of Social Protection illness benefit data for 2009, with the calculation of population attributable fractions of days absent from work for overweight and obesity-related co-morbid conditions. For Northern Ireland, the 2005/6 Health and Wellbeing Survey dataset was analysed. These analyses were augmented by an analysis of sickness benefits data obtained from the Analytical Services Unit of the Department of Social Development (Northern Ireland). Premature mortality Mortality data were obtained from the Irish Central Statistics Office (CSO) and the Northern Ireland Statistics and Research Agency (NISRA) to estimate the impact of obesity and overweight on premature mortality.

34 Methods of analyses for indirect costs Population attributable fractions (PAFs) for death and absenteeism (indirectly estimated from disability claims), associated with the defined list of overweight and obesity-related conditions, were derived for each jurisdiction using separate risk estimates for overweight and obesity and, wherever available, separate relative risk estimates for males and females. Deaths were weighted using years of potential life lost (YPLL) up to age 75. Discount rate of 4% applied Productivity loss was estimated using both human-capital and friction-cost methods. Main results based on estimated human capital costs

35 Overview Brief overview of the obesity epidemic in adults and children in Ireland Burden of disease linked to obesity Background to the Irish Cost of Obesity Study including earlier international work on this issue Methods used in Irish Cost of Obesity Study Main findings and Recommendations Pitfalls and limitations

36 Main Results Republic of Ireland Northern Ireland (PPP Irish 2009 ) Direct costs 398,615, ,406,641 Indirect costs 728,968, ,917,113 Total costs 1,127,584, ,323,754

37 Results- Direct Costs Republic of Ireland Cost ROI General Practice 22,900,000 Hospital inpatient care 134,383,667 Hospital outpatient care 6,890,000 Drugs 234,441,904 Total 398,615,581

38 Results-Direct Costs Northern Ireland Direct costs NI General Practice 7,411,564 Hospital Inpatient Care 42,920,805 Drugs 77,074,272 Total 127,406,641

39 Main contributing conditions to Direct Healthcare Costs Cardiovascular disease Type II Diabetes Colon Cancer Stroke Gallbladder Disease

40 Results-Indirect due to Productivity Loss ROI Indirect cost ROI Absenteeism 135,977,068 Premature Mortality 592,991,594 Total 728,968,662

41 Results-Indirect due to Productivity Loss NI Indirect cost NI Absenteeism 235,500,000 Premature Mortality 147,417,113 Total 382,917,113

42 Main Drivers of Cost Premature Mortality Coronary Heart Disease Absenteeism Low Back Pain

43 Main Recommendations The findings highlight the extent of societal involvement in diet and health and the limitations of approaches which emphasise the importance of personal agencyin relation to diet and health The food sector is currently regulated to ensure food safety. Policy makers need to consider whether there is a need to extend this regulatory framework to address the effects of diet on health and wellbeing. Need for both population based and targeted (high risk group) strategies to tackle the obesity epidemic Key policies and actions will need to occur outside the health sector Workplace interventions needed to reduce the problem of Low Back Pain in the overweight and obese

44 Recommendations (Cont) Need for significant investment in research to examine the effect of fiscal and other government policies on consumer purchasing and their impact on overweight and obesity Need for modelling the overweight and obesity associated illness burden and costs into the future National surveys need to be designed to facilitate such cost of illness studies, and to evaluate the effects of public health interventions

45 Relative Price Changes for Fresh Fruits and Vegetables, Sugars and Sweets, and Carbonated Drinks,

46 Limitations of cost of illness studies Accepted that overweight and obesity increase the risk of illness, absenteeism from the workplace and early death, but the magnitude of these effects in the population is measured with poor precision Even greater imprecision in the estimation of associated direct healthcare cost and indirect societal costs. Variable and inconsistent data on absenteeism and limited primary research on presenteeism Potential problem of double counting in the application of the PAF method Effects on quality of life and mental wellbeing not addressed Uncertainty in relation to how best to value productivity loss: human capital versus friction costs methods and economic and social contribution of retired people? Need to consider the wide uncertainty bounds/confidence intervals around the summary cost estimates.

47 Limitations of cost of illness studies Given the extent of fixed staffing and infrastructure cost in health systems, how much of the estimated costs would be saved if the current burden of overweight and obesity were reduced.? Value of cost of illness studies derives primarily from their ability to inform discussion of the relative economic burden associated with major health problems as opposed to the precise quantification of absolute costs. It is arguable that estimation of the absolute burden or costs of illness provides a poor measure of relative need. The latter (need) is determined both by the burden of disease and the capacity to benefit from interventions. Under ideal circumstances, the priority assigned to overweight and obesity in public policy should be driven primarily by estimates of the incremental costs and the incremental benefits of interventions to prevent and/or manage overweight and obesity.

48 Thank you

The Economic Cost of Overweight and Obesity in Ireland. Dr. Anne Dee 17/01/2014

The Economic Cost of Overweight and Obesity in Ireland. Dr. Anne Dee 17/01/2014 The Economic Cost of Overweight and Obesity in Ireland Dr. Anne Dee 17/01/2014 Acknowledgements UCC Professor Ivan Perry, Dr. Anne Dee, Karen Kearns NUIG Professor Ciaran O Neill, Dr. Edel Doherty, Dr.

More information

The cost of overweight and obesity on the island of Ireland

The cost of overweight and obesity on the island of Ireland The cost of overweight and obesity on the island of Ireland The cost of overweight and obesity on the island of Ireland Principal Investigator: Professor Ivan J. Perry, Department of Epidemiology and Public

More information

LIFETIME COST OF CHILDHOOD OBESITY JRC Ispra (VA), Italy November 2015

LIFETIME COST OF CHILDHOOD OBESITY JRC Ispra (VA), Italy November 2015 LIFETIME COST OF CHILDHOOD OBESITY JRC Ispra (VA), Italy. 12 13 November 2015 Kevin Balanda PhD, FFPH Director, Research & Information, Institute of Public Health in Ireland 1. EU JOINT ACTION ON NUTRITION

More information

WORK PACKAGE 4: LIFETIME COST OF CHILDHOOD OBESITY

WORK PACKAGE 4: LIFETIME COST OF CHILDHOOD OBESITY JOINT ACTION ON NUTRITION AND PHYSICAL ACTIVITY - JANPA KICK-OFF MEETING LUXEMBOURG, 29-30 SEPTEMBER 2015 WORK PACKAGE 4: LIFETIME COST OF CHILDHOOD OBESITY Lead: Prof. Kevin Balanda Institute of Public

More information

Obesity: Trends, Impact, Complexity

Obesity: Trends, Impact, Complexity Obesity: Trends, Impact, Complexity Ross A. Hammond, Ph.D. Director, Center on Social Dynamics & Policy Senior Fellow, Economic Studies Program The Brookings Institution Attorneys General Education Program

More information

EConDA Economics of Chronic Diseases

EConDA Economics of Chronic Diseases EConDA Economics of Chronic Diseases www.econdaproject.eu Funding from the European Union in the framework of the Health Programme Abbygail Jaccard Deputy Director of Public Health Modelling UK Health

More information

The direct and indirect costs of both overweight and obesity: a systematic review

The direct and indirect costs of both overweight and obesity: a systematic review Dee et al. BMC Research Notes 2014, 7:242 RESEARCH ARTICLE Open Access The direct and indirect costs of both overweight and obesity: a systematic review Anne Dee 1*, Karen Kearns 2, Ciaran O Neill 3, Linda

More information

Cancers attributable to excess body weight in Canada in D Zakaria, A Shaw Public Health Agency of Canada

Cancers attributable to excess body weight in Canada in D Zakaria, A Shaw Public Health Agency of Canada Cancers attributable to excess body weight in Canada in 2010 D Zakaria, A Shaw Public Health Agency of Canada Introduction Cancer is a huge burden in Canada: Nearly 50% of Canadians are expected to be

More information

Making a Business Case for Wellness. Diane Andrea, RD, LD Wellness Consultant

Making a Business Case for Wellness. Diane Andrea, RD, LD Wellness Consultant Making a Business Case for Wellness Diane Andrea, RD, LD Wellness Consultant Overview of Presentation 1 Cost of unhealthy behaviors 2 Return on Investment 3 Biggest bang for your wellness buck What is

More information

Media centre Obesity and overweight

Media centre Obesity and overweight 1 of 5 06/05/2016 4:54 PM Media centre Obesity and overweight Fact sheet N 311 Updated January 2015 Key facts Worldwide obesity has more than doubled since 1980. In 2014, more than 1.9 billion adults,

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association What proportion of cancer is due to obesity? Tony Blakely, Diana Sarfati, Caroline Shaw The evidence linking overweight and

More information

Bariatric Surgery: A Cost-effective Treatment of Obesity?

Bariatric Surgery: A Cost-effective Treatment of Obesity? Bariatric Surgery: A Cost-effective Treatment of Obesity? Shaneeta M. Johnson MD FACS FASMBS 2018 NMA Professional Development Seminar Congressional Black Caucus Foundation Annual Legislative Conference

More information

Chronic Conditions The need for a comprehensive public health approach

Chronic Conditions The need for a comprehensive public health approach Chronic Conditions The need for a comprehensive public health approach Olga McDaid PhD Scholar HRB PhD Programme for Health Services Research, Trinity College Dublin Supervisors Prof. Charles Normand,

More information

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth Kevin Klowden Managing Economist Milken Institute (310) 570

More information

MPhil/PhD Application Form

MPhil/PhD Application Form Department of Economics MPhil/PhD Application Form Please enter your full correspondence details here: Applicant (Student) Details Title (Mr, Miss, Mrs) Forename Surname Telephone No. Fax No. Email Address

More information

Economic Evaluation. Introduction to Economic Evaluation

Economic Evaluation. Introduction to Economic Evaluation Economic Evaluation Introduction to Economic Evaluation This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of

More information

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside)

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside) Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside) Note: This paper is based on a report originally produced by Dr

More information

Tobacco Health Cost in Egypt

Tobacco Health Cost in Egypt 1.Introduction 1.1 Overview Interest in the health cost of smoking originates from the desire to identify the economic burden inflicted by smoking on a society. This burden consists of medical costs plus

More information

Nutrition and Health Foundation Seminar

Nutrition and Health Foundation Seminar Nutrition and Health Foundation Seminar Presentation by Brian Mullen Health Promotion Policy Unit Department of Health and Children Prevalence of overweight and obesity has been described by WHO as an

More information

FORESIGHT Tackling Obesities: Future Choices Project Report Government Office for Science

FORESIGHT Tackling Obesities: Future Choices Project Report Government Office for Science 1. Introduction FORESIGHT Tackling Obesities: Future Choices Project Report Government Office for Science The UK Government s Foresight Programme creates challenging visions of the future to help inform

More information

MENTAL HEALTH, BEREAVEMENT AND SUICIDE

MENTAL HEALTH, BEREAVEMENT AND SUICIDE MENTAL HEALTH, BEREAVEMENT AND SUICIDE Using administrative data to understand mental health in Northern Ireland: Results from two exemplar projects Dr Aideen Maguire 1, Dr Mark McCann 2, Dr John Moriarty

More information

Innovations in Obesity: A Policy Perspective

Innovations in Obesity: A Policy Perspective Innovations in Obesity: A Policy Perspective Nutrition & Health Foundation October 2011 Dr Tony Holohan, Chief Medical Officer Overview Where we are now - health status and the reform programme Priorities

More information

Why the Increase In Obesity

Why the Increase In Obesity Obesity From an Economist s Perspective Eric Finkelstein, PhD, MHA RTI INTERNATIONAL The Economics of Obesity (outline) Why the Increase in Obesity Rates Adverse Health Consequences Why do (or should)

More information

Human and Fiscal Implications of Heart Disease and Stroke

Human and Fiscal Implications of Heart Disease and Stroke 1 Texas Council on Cardiovascular Disease and Stroke Report for the 84 th Regular Texas Legislative Session Heart Disease and Stroke in Texas: A Call to Action Enacted by the 76 th Legislature (House Bill

More information

Food Choice at Work From Evaluation to Practical Application in Everyday Workplace Settings

Food Choice at Work From Evaluation to Practical Application in Everyday Workplace Settings Food Choice at Work From Evaluation to Practical Application in Everyday Workplace Settings Clare Kelly Food Choice at Work Ltd Department of Epidemiology and Public Health University College Cork, Ireland

More information

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program NATIONAL COST OF OBESITY SEMINAR Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program 1 INTRODUCTION According to the Center of Disease Control and Prevention, the American society

More information

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY. OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY THE OREGON DEPARTMENT OF HUMAN SERVICES HEALTH SERVICES HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM www.healthoregon.org/hpcdp Contents

More information

Public Health Association of Australia: Policy-at-a-glance Prevention and Management of Overweight and Obesity in Australia Policy

Public Health Association of Australia: Policy-at-a-glance Prevention and Management of Overweight and Obesity in Australia Policy Public Health Association of Australia: Policy-at-a-glance Prevention and Management of Overweight and Obesity in Australia Policy Key message: PHAA will 1. Advocate that Federal, State and Territory governments:

More information

Making Economic Evaluation Fit for Purpose to Guide Resource Allocation Decisions

Making Economic Evaluation Fit for Purpose to Guide Resource Allocation Decisions Making Economic Evaluation Fit for Purpose to Guide Resource Allocation Decisions Mark Sculpher, PhD Professor of Health Economics Centre for Health Economics University of York, UK Outline Policy context

More information

Cost-effectiveness of apremilast (Otezla )

Cost-effectiveness of apremilast (Otezla ) Cost-effectiveness of apremilast (Otezla ) alone or in combination with Disease Modifying Antirheumatic Drugs (DMARDs) for the treatment of active psoriatic arthritis in adult patients who have had an

More information

National Center for Chronic Disease Prevention and Health Promotion. Overweight and Obesity Frequently Asked Questions (FAQs)

National Center for Chronic Disease Prevention and Health Promotion. Overweight and Obesity Frequently Asked Questions (FAQs) National Center for Chronic Disease Prevention and Health Promotion Overweight and Obesity Frequently Asked Questions (FAQs) How many American adults are overweight or obese? How many American children

More information

Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN)

Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN) The Costs of Smoking Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN) Why Do We Study the Cost of Smoking? To assess the economic impact of smoking behavior

More information

The Cost Effectiveness of Omacor post-myocardial infarction in the Irish Healthcare Setting

The Cost Effectiveness of Omacor post-myocardial infarction in the Irish Healthcare Setting The Cost Effectiveness of Omacor post-myocardial infarction in the Irish Healthcare Setting April 2013 1. Omacor is a concentrated preparation of omega-3-acid ethyl esters that contains 46% eicosapentaenoic

More information

Diabetes expenditure, burden of disease and management in 5 EU countries Panos Kanavos, Stacey van den Aardweg and Willemien Schurer

Diabetes expenditure, burden of disease and management in 5 EU countries Panos Kanavos, Stacey van den Aardweg and Willemien Schurer Diabetes expenditure, burden of disease and management in 5 EU countries Panos Kanavos, Stacey van den Aardweg and Willemien Schurer LSE Health, London School of Economics January 2012 Acknowledgements

More information

A BRIEF OF A BILL ENTITLED THE

A BRIEF OF A BILL ENTITLED THE A BRIEF OF A BILL ENTITLED THE CUSTOMS TARIFF AMENDMENT (NO 2) BILL 2018 Prepared for The Honourable Kim N. Wilson, JP, MP Minister of Health 8 th June 2018 CUSTOMS TARIFF AMENDMENT (No 2) BILL 2018 Overview

More information

Food Choice at Work Study: Effectiveness of Complex Workplace Dietary Interventions on Dietary Behaviours and Diet-Related Disease Risk.

Food Choice at Work Study: Effectiveness of Complex Workplace Dietary Interventions on Dietary Behaviours and Diet-Related Disease Risk. Food Choice at Work Study: Effectiveness of Complex Workplace Dietary Interventions on Dietary Behaviours and Diet-Related Disease Risk. SARAH FITZGERALD HRB PHD SCHOLAR PRINCIPAL INVESTIGATOR: PROF IVAN

More information

Appendix 2: Cost-effectiveness modeling methods

Appendix 2: Cost-effectiveness modeling methods Appendix 2: Cost-effectiveness modeling methods A model was developed to evaluate the cost-effectiveness of interventions aiming to reduce overweight and obesity. The model evaluates intervention cost-effectiveness

More information

- Description, Objectives, Operational Framework

- Description, Objectives, Operational Framework 2 1. CNCD - Overview (significance, causes, burden) 2. CDAP - Description, Objectives, Operational Framework 3. Research Findings of Study on CDAP - Research Objectives and Methodology - Limitations and

More information

The Economic Burden of Hypercholesterolaemia

The Economic Burden of Hypercholesterolaemia The Economic Burden of Hypercholesterolaemia November 2018 TABLE OF CONTENTS Acronyms 3 Executive Summary 4 Introduction 5 Approach 5 Structure of the report 5 Economic burden of hypercholesterolaemia

More information

The local healthcare system: Focusing on health

The local healthcare system: Focusing on health The local healthcare system: Focusing on health Sian Griffiths Professor of Public Health Director of the School of Public Health Chairman, Department of Community and Family Medicine The Chinese University

More information

The Complete Health Improvement Program. Healthnetwork Foundation Webinar November 2013 Amy Mechley, M.D. The Christ Hospital Health Network

The Complete Health Improvement Program. Healthnetwork Foundation Webinar November 2013 Amy Mechley, M.D. The Christ Hospital Health Network The Complete Health Improvement Program Healthnetwork Foundation Webinar November 2013 Amy Mechley, M.D. The Christ Hospital Health Network Current State Of Affairs Health Care Costs Chronic Diseases Absenteeism

More information

Treatment of hypertension to achieve blood pressure control

Treatment of hypertension to achieve blood pressure control Treatment of hypertension to achieve blood pressure control Item Type Report Authors Peter Mas-Mollinedo Publisher Irish Heart Foundation (IHF) Download date 01/11/2018 18:07:44 Link to Item http://hdl.handle.net/10147/310910

More information

FRUIT AND VEGETABLES CONSUMPTION AND PREVENTION OF CHRONIC DIET-RELATED NON- COMMUNICABLE DISEASES. Mike Rayner Chair EHN Expert Group on Nutrition

FRUIT AND VEGETABLES CONSUMPTION AND PREVENTION OF CHRONIC DIET-RELATED NON- COMMUNICABLE DISEASES. Mike Rayner Chair EHN Expert Group on Nutrition British Heart Foundation Health Promotion Research Group FRUIT AND VEGETABLES CONSUMPTION AND PREVENTION OF CHRONIC DIET-RELATED NON- COMMUNICABLE DISEASES Mike Rayner Chair EHN Expert Group on Nutrition

More information

Briefing. OBESITY IN in SCOTLAND. Facts. Definition. Calculate your BMI

Briefing. OBESITY IN in SCOTLAND. Facts. Definition. Calculate your BMI OBESITY IN in SCOTLAND July 2016 Briefing Facts Obesity is defined as Body Mass Index over 30 kg/m 2, which records weight adjusted for height Obesity is a serious public health threat in Scotland: affecting

More information

Chronic conditions, physical function and health care use:

Chronic conditions, physical function and health care use: Chronic conditions, physical function and health care use: Findings from the Australian Longitudinal Study on Women s Health Authors: Julie Byles Richard Hockey Deirdre McLaughlin Annette Dobson Wendy

More information

ASIA-PACIFIC HEART HEALTH CHARTER

ASIA-PACIFIC HEART HEALTH CHARTER ASIA-PACIFIC HEART HEALTH CHARTER The Asia-Pacific Heart Health Charter has been developed by the Asia-Pacific Heart Network in collaboration with Asia Pacific Society of Cardiology to help stem the growing

More information

The Value of Providing Collaborative Care Models For Treating Employees with Depression

The Value of Providing Collaborative Care Models For Treating Employees with Depression The Value of Providing Collaborative Care Models For Treating Employees with Depression Summary Depression is one of the costliest health issues for employers because of its high prevalence and co-morbidity

More information

Value Based Pay for Performance Results & Highlights Measurement Year September 2017

Value Based Pay for Performance Results & Highlights Measurement Year September 2017 Value Based Pay for Performance Results & Highlights Measurement Year 2016 September 2017 IHA s Value Based Pay for Performance (VBP4P) ~200 Medical Groups & IPAs 9 Health Plans Common Measurement Public

More information

Randy Wexler, MD, MPH Associate Professor and Clinical Vice Chair Department of Family Medicine The Ohio State University Wexner Medical Center

Randy Wexler, MD, MPH Associate Professor and Clinical Vice Chair Department of Family Medicine The Ohio State University Wexner Medical Center Obesity Randy Wexler, MD, MPH Associate Professor and Clinical Vice Chair Department of Family Medicine The Ohio State University Wexner Medical Center US Adults Obesity prevalence ranges from 21.0% in

More information

Managing Overweight and Obesity among Adults. Report on Economic Modelling and Cost Consequence Analysis

Managing Overweight and Obesity among Adults. Report on Economic Modelling and Cost Consequence Analysis Managing Overweight and Obesity among Adults Report on Economic Modelling and Cost Consequence Analysis Martin Brown, Tim Marsh, Lise Retat UK Health Forum Ric Fordham, Marc Suhrcke, David Turner, Richard

More information

The Obesity Epidemic: Its Impact in the Workplace and What Employers Can Do

The Obesity Epidemic: Its Impact in the Workplace and What Employers Can Do 1 The Obesity Epidemic: Its Impact in the Workplace and What Employers Can Do Dr. Monali Misra, MD, FRCS(C), FACS Assistant Professor Department of Surgery, St. Joseph s Healthcare, McMaster University

More information

Statement of Objectives:

Statement of Objectives: Essential Standard 7.NPA.3 - Analyze the relationship of nutrition, fitness, and healthy weight management to the prevention of diseases such as diabetes, obesity, cardiovascular diseases, and eating disorders.

More information

UIC Obesity Research Roundtable

UIC Obesity Research Roundtable UIC Obesity Research Roundtable Sponsored by: Research Development Service, OVCR Institute for Health Research and Policy Frank J. Chaloupka Distinguished Professor Economics, Health Policy and Administration

More information

Healthcare Utilisation and Screening

Healthcare Utilisation and Screening 3 Health Insurance and Healthcare Utilisation and Screening Patrick Moore, Siobhan Scarlett and Anne Nolan Contents Key Findings... 48 3.1 Introduction... 49 3.2 Healthcare Entitlement Status... 49 3.3

More information

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:

More information

An Overview of Health Economics Data and Expertise in Cancer

An Overview of Health Economics Data and Expertise in Cancer An Overview of Health Economics Data and Expertise in Cancer Peter Smith, (Professor of Health Policy, Imperial College London) Mauro Laudicella (Research Fellow, Imperial College London) Source: A. Maynard

More information

Associate Parliamentary Food and Health Forum. Presentation on the Foresight report Tackling Obesities: Future Choices

Associate Parliamentary Food and Health Forum. Presentation on the Foresight report Tackling Obesities: Future Choices Associate Parliamentary Food and Health Forum Presentation on the report Tackling Obesities: Future Choices House of Lords Committee Room G 1 April 2008 Associate Parliamentary Food and Health Forum Presentation

More information

Setting The setting was community. The economic study was carried out in the USA.

Setting The setting was community. The economic study was carried out in the USA. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children Lieu T A, Ray G T, Black S R, Butler J C, Klein J O, Breiman R F, Miller M A, Shinefield H R Record

More information

Trends in Irish cancer incidence with predictions to 2020

Trends in Irish cancer incidence with predictions to 2020 Trends in Irish cancer incidence 1994-22 with predictions to 22 Trends in Irish cancer incidence 1994-22 with projections to 22 National Cancer Registry June 26 1 Acknowledgements. I would like to thank

More information

Expenditure Share United States, 2003

Expenditure Share United States, 2003 Expenditure Share United States, 2003 Source: MEPS Chronic Disease Share of MEPS Expenditure ( Percent ) Share of Health Care Expenditure Breast Cancer 0.5 0.3 Colon Cancer 0.8 0.5 Lung Cancer 0.6 0.3

More information

REFERENCE CODE GDHCER022 PUBLICAT ION DATE AUGUST 2013 OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022

REFERENCE CODE GDHCER022 PUBLICAT ION DATE AUGUST 2013 OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022 REFERENCE CODE GDHCER022 PUBLICAT ION DATE AUGUST 2013 OVERWEIGHT AND OBESITY - Executive Summary Obesity is an escalating global public health problem that has reached pandemic proportions. It is caused

More information

Country report Serbia April 2017

Country report Serbia April 2017 Country report Serbia April 2017 Report by Vojislav Giga, MD, PhD, Cardiologist et al. National CVD Prevention Coordinator for Serbia Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia Prepared

More information

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women (Lancet. 2017 Mar 25;389(10075):1229-1237) 1 Silvia STRINGHINI Senior

More information

ARE STROKE UNITS COST EFFECTIVE? EVIDENCE FROM A NEW ZEALAND STROKE INCIDENCE AND POPULATION-BASED STUDY

ARE STROKE UNITS COST EFFECTIVE? EVIDENCE FROM A NEW ZEALAND STROKE INCIDENCE AND POPULATION-BASED STUDY ARE STROKE UNITS COST EFFECTIVE? EVIDENCE FROM A NEW ZEALAND STROKE INCIDENCE AND POPULATION-BASED STUDY Braden Te Ao, Ph.D. Centre for Health Services Research & Policy, University of Auckland, National

More information

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division The costs of poor mental health Estimates of Direct and Indirect Costs of Mental Illness 1 All

More information

Information Management. A System We Can Count On. Chronic Conditions. in the Central East LHIN

Information Management. A System We Can Count On. Chronic Conditions. in the Central East LHIN Information Management A System We Can Count On Chronic Conditions in the Central East LHIN Health System Intelligence Project October 2007 Table of Contents About HSIP..................................ii

More information

HEALTHY WEIGHT AND THE WORKPLACE. a guide for employers

HEALTHY WEIGHT AND THE WORKPLACE. a guide for employers HEALTHY WEIGHT AND THE WORKPLACE a guide for employers This Topic Guide has been commissioned and reviewed by Public Health England (PHE), but developed by Health@Work. The purpose is to provide information

More information

Key Diabetes Trends Across Texas 2016

Key Diabetes Trends Across Texas 2016 Texas Business Group on Health presents Snapshot of Key Diabetes Trends Across Texas 2016 Diabetes, along with its sibling - Obesity are costly and serious epidemics, that continue to pose significant

More information

Overweight and obesity: where are we and where are we heading?

Overweight and obesity: where are we and where are we heading? Overweight and obesity: where are we and where are we heading? Harry Rutter harry.rutter@lshtm.ac.uk Prevalence of excess weight among adults aged 16+ years Health Survey for England 1993-2010 70 60 Prevalence

More information

Nutrition and Physical Activity Situational Analysis

Nutrition and Physical Activity Situational Analysis Nutrition and Physical Activity Situational Analysis A Resource to Guide Chronic Disease Prevention in Alberta Executive Summary December 2010 Prepared by: Alberta Health Services, AHS Overview Intrinsic

More information

Costing the burden of ill health related to physical inactivity for Scotland

Costing the burden of ill health related to physical inactivity for Scotland Costing the burden of ill health related to physical inactivity for Scotland Written by Dr Nick Townsend, Senior Researcher, BHF Centre on Population Approaches for Non-Communicable Disease Prevention,

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Strategy,, policy and commissioning to delay or prevent ent of dementia, bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

Memorias Convención Internacional de Salud Pública. Cuba Salud La Habana 3-7 de diciembre de 2012 ISBN

Memorias Convención Internacional de Salud Pública. Cuba Salud La Habana 3-7 de diciembre de 2012 ISBN Primary Health Care and the Management of the Ambulatory Care Sensitive Conditions of Hypertension and Diabetes in Jamaica Charlton McFarlane Ministry of Health and University of the West Indies and Natalie

More information

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth Ross DeVol Director, Center for Health Economics Director,

More information

NICE offer to STPs: CVD prevention

NICE offer to STPs: CVD prevention NICE offer to STPs: CVD prevention Zoe Girdis Regional Technical Adviser South of England and Channel Islands NICE support for STPs Based on the best available evidence of what works and is costeffective,

More information

The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S

The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S Record Status This is a critical abstract of an economic evaluation

More information

Public Health Annual Scientific Conference Wednesday 10 June Making Life Better: Improving Health and Care for Adults

Public Health Annual Scientific Conference Wednesday 10 June Making Life Better: Improving Health and Care for Adults Public Health Annual Scientific Conference Wednesday 10 June 2015 Making Life Better: Improving Health and Care for Adults Dr Carolyn Harper Director of Public Health Overview Why Adults? Key features

More information

Executive Summary: Toi Te Ora s Childhood Obesity Prevention Strategy ( )

Executive Summary: Toi Te Ora s Childhood Obesity Prevention Strategy ( ) Executive Summary: Toi Te Ora s Childhood Obesity Prevention Strategy (2013 2023) This briefing paper has been developed by Toi Te Ora Public Health Service (Toi Te Ora) to provide an evidence-based strategic

More information

Economic effects of beta-blocker therapy in patients with heart failure Cowper P A, DeLong E R, Whellan D J, LaPointe N M, Califf R M

Economic effects of beta-blocker therapy in patients with heart failure Cowper P A, DeLong E R, Whellan D J, LaPointe N M, Califf R M Economic effects of beta-blocker therapy in patients with heart failure Cowper P A, DeLong E R, Whellan D J, LaPointe N M, Califf R M Record Status This is a critical abstract of an economic evaluation

More information

A cost-utility analysis of treatment options for inguinal hernia in 1,513,008 adult patients Stylopoulos N, Gazelle G S, Rattner D W

A cost-utility analysis of treatment options for inguinal hernia in 1,513,008 adult patients Stylopoulos N, Gazelle G S, Rattner D W A cost-utility analysis of treatment options for inguinal hernia in 1,513,008 adult patients Stylopoulos N, Gazelle G S, Rattner D W Record Status This is a critical abstract of an economic evaluation

More information

Community Health Needs Assessment Centra Southside Medical Center

Community Health Needs Assessment Centra Southside Medical Center Community Health Needs Assessment Centra Southside Medical Center 2017-2019 Healthy People 2020 Healthy People provides a framework for prevention for communities in the U.S. Healthy People 2020 is a comprehensive

More information

Key Diabetes Trends Across Texas 2016

Key Diabetes Trends Across Texas 2016 Texas Business Group on Health presents Snapshot of Key Diabetes Trends Across Texas 2016 Diabetes, along with its sibling - Obesity are costly and serious epidemics, that continue to pose significant

More information

Healthcare expenditure and productivity cost savings resulting from increased intake of grain fibre in Australia.

Healthcare expenditure and productivity cost savings resulting from increased intake of grain fibre in Australia. Healthcare expenditure and productivity cost savings resulting from increased intake of grain fibre in Australia. WHITE PAPER ACKNOWLEDGEMENT Kellogg Australia commissioned Nutrition Research Australia

More information

Implementation plan for the systems approach to suicide prevention in NSW

Implementation plan for the systems approach to suicide prevention in NSW Implementation plan for the systems approach to suicide prevention in NSW Summary paper October 2015 Putting health in mind IMPLEMENTATION PLAN FOR THE SYSTEMS APPROACH TO SUICIDE PREVENTION IN NSW Rationale

More information

WHO Draft Guideline: Sugars intake for adults and children. About the NCD Alliance. Summary:

WHO Draft Guideline: Sugars intake for adults and children. About the NCD Alliance. Summary: WHO Draft Guideline: Sugars intake for adults and children About the NCD Alliance The NCD Alliance is a unique civil society network of over 2,000 organizations in more than 170 countries focused on raising

More information

Supplementary information file

Supplementary information file Supplementary information file 1 Annex 1. Search terms and review process Review 1: BMI data Pubmed, google scholar, article reference lists, author contacts and country statistical databases were searched

More information

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight. Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research

More information

Access to Proven Therapies

Access to Proven Therapies Access to Proven Therapies Obesity is a life-threatening disease affecting 34% of adults in the U.S. Between 2000 and 2005, obesity increased by 24%, morbid obesity by 50%, and super obesity by 75%. 18%

More information

Medicaid Report: New Hampshire and Vermont. Preventative Care and Obesity

Medicaid Report: New Hampshire and Vermont. Preventative Care and Obesity Medicaid Report: New Hampshire and Vermont Preventative Care and Obesity PRS Policy Brief 0506-11 October 24, 2006 Prepared by: Stephanie Lawrence This report was written by undergraduate students at Dartmouth

More information

The Economic Consequences of Diabetes: More than just a health issue

The Economic Consequences of Diabetes: More than just a health issue The Economic Consequences of Diabetes: More than just a health issue Dr Hannah Carter ADEA-QLD Conference 21 April 2018 Overview The Cost of Illness (COI) framework Direct costs of diabetes Indirect costs

More information

Americas Deadly Disease. Myths of how obesity came to be Eating food high in fructose, syrup, or a virus An epidemic disease

Americas Deadly Disease. Myths of how obesity came to be Eating food high in fructose, syrup, or a virus An epidemic disease Americas Deadly Disease Myths of how obesity came to be Eating food high in fructose, syrup, or a virus An epidemic disease History of Obesity In 1950 obesity was ignored by the public Major medical journals

More information

INSIGHTS INTO ADHD CARE IN GERMANY BASED ON SHI CLAIMS DATA 03. March Results of the CoCA Study (Horizon 2020)

INSIGHTS INTO ADHD CARE IN GERMANY BASED ON SHI CLAIMS DATA 03. March Results of the CoCA Study (Horizon 2020) 03. March 2017 INSIGHTS INTO ADHD CARE IN GERMANY BASED ON SHI CLAIMS DATA Results of the CoCA Study (Horizon 2020) Who are we? HGC looks back on close to 30 years of experience in the health care sector

More information

ALCOHOL AND CANCER TRENDS: INTERVENTION SCENARIOS

ALCOHOL AND CANCER TRENDS: INTERVENTION SCENARIOS ALCOHOL AND CANCER TRENDS: INTERVENTION SCENARIOS PROJECTING TRENDS IN ALCOHOL CONSUMPTION AND ALCOHOL-RELATED HARM IN ENGLAND FROM 2015 TO 2035 AND ESTIMATING THE IMPACT OF POTENTIAL MINIMUM UNIT PRICING

More information

Health and Economic Consequences of Obesity and Overweight in Pakistan

Health and Economic Consequences of Obesity and Overweight in Pakistan Health and Economic Consequences of Obesity and Overweight in Pakistan Maryam Naeem Satti MS Health Economics Thesis Supervisors: Dr Durre Nayab Dr Mahmood Khalid 6 th March, 2015 PIDE Introduction Overweight

More information

Obesity and Medical Nutrition Therapy. Deborah B. Munchmeyer Program Manager, SCDHHS Coverage and Benefit Design March 10, 2018

Obesity and Medical Nutrition Therapy. Deborah B. Munchmeyer Program Manager, SCDHHS Coverage and Benefit Design March 10, 2018 Obesity and Medical Nutrition Therapy Deborah B. Munchmeyer Program Manager, SCDHHS Coverage and Benefit Design March 10, 2018 Obesity What, Why and How? Source: American Association of Clinical Endocrinologists

More information

The first step to Getting Australia s Health on Track

The first step to Getting Australia s Health on Track 2017 The first step to Getting Australia s Health on Track Heart Health is the sequential report to the policy roadmap Getting Australia s Health on Track and outlines a national implementation strategy

More information

Real-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017

Real-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017 Real-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017 One of the aims of GARFIELD-AF is to assist physicians in their understanding of the risk of stroke in patients with atrial

More information

Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives

Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta Justine Fitzpatrick 19 th February 2008- Public Health WORKS Speaker Series Learning

More information

Ovarian Cancer Australia submission to the Senate Select Committee into Funding for Research into Cancers with Low Survival Rates

Ovarian Cancer Australia submission to the Senate Select Committee into Funding for Research into Cancers with Low Survival Rates Queen Victoria Women s Centre Level 1, 210 Lonsdale Street Melbourne, VIC 3000 T 1300 660 334 F +61 3 9569 3945 30 April 2017 www.ovariancancer.net.au Committee Secretary Select Committee into Funding

More information